EDGAR Filing Documents for 0001493152-15-005352

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-005352

Filing Date

2015-11-12

Accepted

2015-11-12 16:17:50

Documents

Period of Report

2015-09-30

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	793383
2		ex31-1.htm	EX-31.1	16964
3		ex31-2.htm	EX-31.2	16970
4		ex32-1.htm	EX-32.1	7416
5		ex32-2.htm	EX-32.2	7522
	Complete submission text file	0001493152-15-005352.txt		6876241

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	corx-20150930.xml	EX-101.INS	1075937
7	XBRL SCHEMA FILE	corx-20150930.xsd	EX-101.SCH	87176
8	XBRL CALCULATION FILE	corx-20150930_cal.xml	EX-101.CAL	49235
9	XBRL DEFINITION FILE	corx-20150930_def.xml	EX-101.DEF	377320
10	XBRL LABEL FILE	corx-20150930_lab.xml	EX-101.LAB	599457
11	XBRL PRESENTATION FILE	corx-20150930_pre.xml	EX-101.PRE	444097

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)